BioSpace News Archive

Endologix LLC today announced the company’s ChEVAS™ (Chimney EndoVascular Aneurysm Sealing) System has been granted a Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).

Novanta Inc. announced today that it has reached an agreement to acquire privately held ATI Industrial Automation (“ATI”) for $172 million upfront in cash and additional contingent cash payments associated with 2021 financial performance.

EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend.

Ancora Heart, Inc ., a company developing a novel therapy to address heart failure, today announced it has closed an $80 million equity financing. Sands Capital, Sio Capital and an undisclosed strategic investor joined all existing investors in this financing.

Fountain Therapeutics today announced that William Greene, M.D., chief executive officer of Fountain, will present a corporate overview at the 2nd Annual LifeSci Partners Private Company Summer Symposium to be held July 21-23, 2021.

FDA and Lyndra align on proposed pivotal trial program, including a PK comparability study and 6-month, double-blind safety study

NLS Pharmaceutics Ltd. announces the appointment of Eric Konofal, M.D., Ph.D., as Chief Scientific Officer.

Dragon SPAC S.p.A. and Napo EU S.p.A. announced the closing of the financing of Dragon SPAC for gross proceeds of approximately 8,830,000 euros, representing the previously announced $10.8 million of funding from Jaguar into Dragon SPAC using funds from the recent registered direct offering for the benefit of Jaguar’s wholly-owned Italian subsidiary.

YishengBio Co., Ltd (“YishengBio”) today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United Arab Emirates Ministry of Health & Prevention.

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that John H. Johnson has been appointed to its Board of Directors, effective July 19, 2021.